Hemostemix Inc. (HMTXF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.49 Million | -6.1 Million | -3.47 Million | -5.97 Million | -3.4 Million | -2.68 Million |
| Net Income | -2.5 Million | -5.23 Million | -6.28 Million | -7.76 Million | -4.86 Million | -6.18 Million |
| Depreciation & Amortization | 223.00 | 495.00 | 1101.00 | 2448.00 | 1688.00 | - |
| Deferred income taxes | - | 486.92 Thousand | -255.78 Thousand | 189.1 Thousand | - | - |
| Stock-based compensation | 149.89 Thousand | 178.68 Thousand | 361.6 Thousand | 2.32 Million | 333.25 Thousand | 1.63 Million |
| Change in working capital | 554.72 Thousand | -1.7 Million | 2.81 Million | -825.72 Thousand | 1.02 Million | 1.86 Million |
| Other non-cash items | 335.86 Thousand | 172.75 Thousand | -114.31 Thousand | 106.04 Thousand | 104.98 Thousand | -6222.00 |
| Investing Cash Flow | - | - | 171.11 Thousand | - | -6138.00 | - |
| Investments in PPE | - | - | - | - | -6138.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 171.11 Thousand | - | - | - |
| Financing Cash Flow | 1.51 Million | 6.01 Million | 3.26 Million | 6.2 Million | 1.96 Million | 201.64 Thousand |
| Debt repayment | - | -2.75 Million | -175 Thousand | -3.91 Million | -1.96 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.51 Million | 3.45 Million | 839.92 Thousand | 8.76 Million | - | 201.64 Thousand |
| Other Financing Activities | -78.1 Thousand | 5.31 Million | 2.6 Million | 1.36 Million | 3.92 Million | 201.64 Thousand |
| Accounts receivables | 113.87 Thousand | 203.76 Thousand | 1.72 Million | -1.98 Million | 115.45 Thousand | -102.09 Thousand |
| Accounts payables | - | - | - | - | - | 709.66 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 440.84 Thousand | -1.9 Million | 1.09 Million | 1.16 Million | 910.68 Thousand | 1.15 Million |
| Cash at beginning of period | 135.74 Thousand | 219.44 Thousand | 257.95 Thousand | 24.06 Thousand | 1.47 Million | 3.95 Million |
| Cash at end of period | 155.41 Thousand | 135.74 Thousand | 219.44 Thousand | 257.95 Thousand | 24.06 Thousand | 1.47 Million |
| Capital Expenditure | - | - | - | - | -6138.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 19.67 Thousand | -83.69 Thousand | -38.5 Thousand | 233.88 Thousand | -1.44 Million | -2.48 Million |
| Free Cash Flow | -1.49 Million | -6.1 Million | -3.47 Million | -5.97 Million | -3.4 Million | -2.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -519.34 Thousand | -475.53 Thousand | -2.5 Million | -683.58 Thousand | -257.24 Thousand | -284.94 Thousand |
| Depreciation & Amortization | 25.00 | 25.00 | 223.00 | 56.00 | 55.00 | 56.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 4143.00 | 4143.00 | 149.89 Thousand | 146.75 Thousand | - | - |
| Change in working capital | -80.75 Thousand | 209.69 Thousand | 554.72 Thousand | 393.99 Thousand | -65.49 Thousand | -196.71 Thousand |
| Other non-cash items | 664.61 Thousand | 148.37 Thousand | 335.86 Thousand | -12.46 Thousand | 256.53 Thousand | 79.84 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 1.51 Million | 18.31 Thousand | 289.4 Thousand | 283.73 Thousand |
| Debt repayment | - | - | - | - | - | -100 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.51 Million | 18.31 Thousand | 320.48 Thousand | 403.54 Thousand |
| Other Financing Activities | - | - | -78.1 Thousand | 18.31 Thousand | -31.07 Thousand | -19.8 Thousand |
| Accounts receivables | 7196.00 | -2864.00 | 113.87 Thousand | 61.63 Thousand | -73.84 Thousand | 14.8 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -80.75 Thousand | 212.56 Thousand | 440.84 Thousand | 332.36 Thousand | 8353.00 | -211.51 Thousand |
| Cash at beginning of period | 35.06 Thousand | 155.41 Thousand | 135.74 Thousand | 377.58 Thousand | 154.32 Thousand | 272.34 Thousand |
| Cash at end of period | 103.75 Thousand | 35.06 Thousand | 155.41 Thousand | 155.41 Thousand | 377.58 Thousand | 154.32 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 68.68 Thousand | -120.34 Thousand | 19.67 Thousand | -222.17 Thousand | 223.26 Thousand | -118.01 Thousand |
| Free Cash Flow | 68.68 Thousand | -120.34 Thousand | -1.49 Million | -240.48 Thousand | -66.14 Thousand | -401.75 Thousand |
SAMG
LUCYW
6278
023810
LBI
GZD